OSCR
Oscar Health, Inc.
OSCR has the edge over PYPL overall, supported by stronger fundamentals.
PYPL
PayPal Holdings, Inc.
PYPL has lower modeled downside risk, despite its lower overall score.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
PYPL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
PYPL's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PYPL.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over PYPL in the historical PE scenario, which offers more potential upside but is not a forecast.
PYPL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.9x | $58.30 | — |
| Current | 11x | $58.30 | — |
| Cheap | 15x | $76.16 | +31% |
| Fair | 26x | $136 | +133% |
| Expensive | 67x | $351 | +503% |
Historical ranges are pointers, not guarantees.
PYPL's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 9.9x next year's earnings.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OSCR has the edge over PYPL on the outlook, with more favorable revenue expectations.
PYPL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect PYPL's earnings to grow and its profitability to improve, with its revenue holding steady.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has returned to profit: it earned $2.47 per share over the past year, after losing money the year before.
PYPL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.87 | +12% |
| Q3 2026 | $5.24 | +5.4% |
| Q2 2026 | $5.29 | +14% |
| Q1 2026 | $5.33 | +20% |
| Q4 2025 | $5.41 | +36% |
| Q3 2025 | $4.97 | +19% |
| Q2 2025 | $4.66 | +13% |
| Q1 2025 | $4.45 | +12% |
| Q4 2024 | $3.99 | +3.9% |
PYPL has the edge over OSCR on earnings, with more consistent year-over-year improvement.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over PYPL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
PYPL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6B | +2% |
| Q2 2026 | $8.7B | +4.8% |
| Q1 2026 | $8.4B | +7.2% |
| Q4 2025 | $8.7B | +3.7% |
| Q3 2025 | $8.4B | +7.3% |
| Q2 2025 | $8.3B | +5.1% |
| Q1 2025 | $7.8B | +1.2% |
| Q4 2024 | $8.4B | +4.2% |
PYPL's revenue has grown year over year every quarter since late 2020: $8.6B last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.7 points |
| Q2 2026 | 16% | -1.7 points |
| Q1 2026 | 18% | -1.8 points |
| Q4 2025 | 17% | +0.2 points |
| Q3 2025 | 18% | +0.3 points |
| Q2 2025 | 18% | +1.3 points |
| Q1 2025 | 20% | +4.5 points |
| Q4 2024 | 17% | -4.3 points |
PYPL has the edge over OSCR on profitability, with a higher operating margin.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over PYPL on cash flow, with more consistent year-over-year improvement.
PYPL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | -17% |
| Q2 2026 | $1.8B | +157% |
| Q1 2026 | $903M | -6.3% |
| Q4 2025 | $2.2B | 0% |
| Q3 2025 | $1.7B | +19% |
| Q2 2025 | $692M | -49% |
| Q1 2025 | $964M | -45% |
| Q4 2024 | $2.2B | -11% |
PYPL's free cash flow was $6.3B over the past year, up 13% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PYPL.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PYPL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.7% | -24M shares |
| 1 year | -11% | -102M shares |
| 3 years | -22% | -240M shares |
| 5 years | -28% | -329M shares |
| Available history | -28% | -329M shares |
PYPL has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.5B |
| Q2 2026 | $1.6B |
| Q1 2026 | $1.5B |
| Q4 2025 | $1.5B |
| Q3 2025 | $1.5B |
| Q2 2025 | $1.6B |
| Q1 2025 | $1.5B |
| Q4 2024 | $1.3B |
PYPL spent $6.1B buying back its own shares over the past year, up 4% from the year before.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over PYPL on leverage, with a lower net debt burden relative to earnings.
PYPL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.5x | Very low |
PYPL's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like PYPL.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
PYPL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.2 | Neutral |
| Stochastic | 61.9 | Neutral |
PYPL's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over PYPL on valuation relative to its sector.
PYPL PE vs Financial Services Sector
| Metric | PYPL | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 10 | 63 | 53 pts below |
PYPL is trading at 11x earnings, a 15% discount to the Financial Services sector's median of 13x.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over PYPL on trend strength, trading above more of its moving averages.
PYPL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.5 | 3.3% above |
| 20 week MA | $55.5 | 5% above |
| 50 week MA | $51.5 | 13% above |
| 100 week MA | $61.6 | 5.4% below |
| 200 week MA | $64.5 | 9.6% below |
PYPL has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 9.6% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over PYPL on returns for 2026, with the stronger performance.
PYPL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $109.4 | $238.6 | +118% |
| 2021 | $238.6 | $192.0 | -20% |
| 2022 | $192.0 | $69.0 | -64% |
| 2023 | $69.0 | $61.4 | -11% |
| 2024 | $61.4 | $86.9 | +41% |
| 2025 | $86.9 | $60.0 | -31% |
| 2026 YTD | $60.0 | $58.3 | -2.8% |
PYPL's yearly returns have swung widely, from +118% in 2020 to −64% in 2022. It's down 2.8% so far in 2026.